The relation between blood pressure components and left atrial volume in the context of left ventricular mass index by Rojek, Marta et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/m
d-journalby
BhD
M
f5ePH
Kav1zEoum
1tQ
fN
4a+kJLhEZgbsIH
o4XM
i0hC
yw
C
X1AW
nYQ
p/IlQ
rH
D
3rL6M
iO
W
0w
/M
H
5e8dQ
ueC
U
zm
ogijM
7K7vO
3LFr1C
6Eoo=
on
04/30/2020
Downloadedfromhttps://journals.lww.com/md-journalbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3rL6MiOW0w/MH5e8dQueCUzmogijM7K7vO3LFr1C6Eoo=on04/30/2020
The relation between blood pressure
components and left atrial volume in
the context of left ventricular mass index
Marta Rojek, MSEa,b,
∗
, Marek Rajzer, MD, PhDa, Wiktoria Wojciechowska, MD, PhDa,
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Abstract
Left atrial enlargement (LAE) is a risk factor for cardiovascular complications and death. In hypertensive patients, LAE is usually due to
left ventricular (LV) hypertrophy and diastolic dysfunction. We aimed to identify factors associated with LAE in patients with increased
and normal left ventricular mass index (LVMI) with reference to pulsatile and steady components of blood pressure (BP).
The study was carried out as a cross-sectional observation. In a group of inhabitants of suburban area of Cracow, Poland, we
measured office, ambulatory and central BP, carotid-femoral pulse wave velocity (PWV), as well as echocardiographic indices and
gathered anthropometric data, information on habits and relevant medical history. Further, with division according to sex-stratified
dichotomised LVMI, we performed correlation analysis to identify possibly significant relations between measures of left atrial volume
and other studied parameters. We also fitted regression models in order to assess the respective value of steady and pulsatile BP
components as factors related to measures of left atrial volume.
The mean age of 205 patients (136 females—66%) was 53.6±8.3 years. We found higher values of PWV, office, ambulatory and
central BPs in the group of LVMI abovemedian value. This group had also greater left atrial volume index (LAVI), which correlated with
LVMI (r=0.36, P< .001) and ratio of early diastolic mitral peak flow velocity to early diastolic mitral annulus mean velocity in tissue
Doppler imaging (E/e0) (r=0.24, P= .04).
In the group of LVMI below the median, LAVI correlated with pulsatile and steady BP components. LAVI was independently
predicted by mean arterial pressure (MAP) obtained from both ambulatory (MAP24h, b= 0.15; P= .045) and office measurements
(MAPoffice, b=0.35; P= .004), but not by pulse pressure.
LV mass and function are the main determinants of LAVI. However, in persons with lower LV mass, LAVI depends on the steady
component of blood pressure, but not pulsatile one. Increased LAVI reflects early changes in response to systemic blood pressure
elevation.
Abbreviations: A = late diastolic mitral peak flow velocity in pulsed Doppler method, BP = blood pressure, cPP = central diastolic
blood pressure, cSBP = central systolic blood pressure, DBP = diastolic blood pressure, DBP24h = diastolic blood pressure within 24
hours in ambulatory blood pressure monitoring, DBPD = diastolic blood pressure within daytime in ambulatory blood pressure
monitoring, DBPN = diastolic blood pressure within nighttime in ambulatory blood pressure monitoring, DBPoffice = diastolic blood
pressure in officemeasurements,E= early diastolicmitral peak flowvelocity in pulsedDopplermethod, e0 = early diastolicmitral annulus
mean velocity in tissue Doppler imaging, LA= left atrium, LAE= left atrial enlargement, LAV= left atrial volume, LAVI = left atrial volume
index, LV= left ventricle, LVEF= left ventricle ejection fraction, LVMI= left ventricularmass index,MAP=meanarterial pressure,MAP24h
= mean arterial pressure within 24 hours in ambulatory blood pressure monitoring, MAPD = mean arterial pressure within daytime in
ambulatory blood pressure monitoring, MAPN = mean arterial pressure within nighttime in ambulatory blood pressure monitoring,
MAPoffice=mean arterial pressure in officemeasurements, PP= pulse pressure, PP24h= pulse pressure within 24 hours in ambulatory
blood pressuremonitoring, PPD= pulse pressurewithin daytime in ambulatory blood pressuremonitoring, PPN= pulse pressurewithin
nighttime inambulatorybloodpressuremonitoring,PPoffice=pulsepressure inofficemeasurements,PWV= carotid-femoral pulsewave
velocity, SBP = systolic blood pressure, SBP24h = systolic blood pressure within 24 hours in ambulatory blood pressure monitoring,
SBPD = systolic blood pressure within daytime in ambulatory blood pressure monitoring, SBPN = systolic blood pressure within
nighttime in ambulatory blood pressure monitoring, SBPoffice = systolic blood pressure in office measurements.
Keywords: arterial stiffness, blood pressure steady and pulsatile components, left atrial volume, left ventricle mass
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1. Introduction
Left atrial enlargement (LAE) is a risk factor for paroxysmal
supraventricular arrhythmias including atrial fibrillation, sys-
temic embolism and death.[1–4] LA enlargement measured by left
atrium volume index (LAVI) was reported to be an independent
predictor of major adverse cardiovascular events among patients
postacute coronary syndrome.[5] LAVI might also be useful in the
prediction of first ischemic stroke and subsequent mortality,[6] as
well as mortality in heart failure patients.[7]
LA volume is a marker of left ventricle (LV) diastolic
dysfunction severity and duration.[4,8] Increased LA volume is
mainly the result of impaired LV filling. In patients with arterial
hypertension, the latter is a consequence of LV hypertrophy and
remodeling. It has been suggested that LV hypertrophy is a link
between hypertension and left atrium enlargement.[9] Further-
more, LA enlargement caused by hypertension is often detected
earlier than LV hypertrophy or dilatation in the course of
hypertensive heart disease.[10,11]
Epidemiological studies proved the relation between cardio-
vascular risk, mortality and morbidity, and the level of both
systolic blood pressure (SBP) and diastolic blood pressure
(DBP).[12–14] However, it has recently been suggested that new
BP parameters, including central aortic BP and carotid-femoral
pulse wave velocity (PWV), should also be analyzed due to their
impact on cardiovascular outcomes. The pulsatile component of
BP has been demonstrated in numerous studies to be involved in
the pathogenesis of atherosclerosis and to be an independent
marker of cardiovascular risk.[15–18]
The pulsatile component, estimated by pulse pressure (PP),
represents BP variation and is affected by heart rate, left ventricle
ejection fraction (LVEF), and predominantly by large artery
stiffness measured by carotid-femoral pulse wave velocity.[15] A
stiffened aorta is less able to adapt to the volume of blood ejected
by the LV, which increases the amplitude of SBP. The early return
of the reflected wave in systole, not in diastole, decreases DBP.
The combined effect is a widened PP.[19] The gold standard of
large artery stiffness assessment recommended by experts is
carotid-femoral pulse wave velocity (PWV).[20] Some studies have
indicated a relation of PWV with LA size in patients with
hypertension.[21,22]
The question of which component of BP, steady represented by
mean arterial pressure (MAP) or pulsatile, is a stronger predictor
of LA enlargement remains unresolved. The results of the
Framingham study indicate that duration of arterial hypertension
and level of SBP, which reflects the pulsatile component of BP, in
the general population are responsible for the rise in LA size.[23]
Several other studies demonstrated a positive relation between PP
and LA enlargement.[24–26] There is lack of sufficient data from
clinical studies about the relation of MAP to LA volume or size.
Therefore, we decided to identify factors associated with LA
enlargement in patients with LVMI below and over the median,
with particular reference to pulsatile and steady components of
blood pressure.
2. Material and methods
2.1. Study population
This observational, cross-sectional study included 205 subjects
(136 females). Participants were recruited from a list of 1851
Morawica and Jeziorzany inhabitants (suburban area of Cracow,
Poland) between June 2015 and January 2016. Of 462 residents
aged between 40 and 65 years, 120 refused to participate, 45
temporarily moved, and 92 were excluded from the study due to
acute or chronic diseases. The exclusion criteria included: heart,
liver, kidney or respiratory failure; coronary artery disease. The
recruited group is representative for the population in given age
range. We obtained anthropometric data, information on habits,
and relevant medical history from all patients with the use of a
standardized questionnaire.
Arterial hypertension was diagnosed according to the 2013
European Society of Hypertension/European Society of Cardiol-
ogy (ESH/ESC) Guidelines.[27] Diabetes was diagnosed according
to World Health Organization recommendations.[28]
The Jagiellonian University Ethics Committee approved the
study protocol (decision number: 122.6120.122.2015 issued
June 25th 2015).
All participants were informed of the purpose and methodolo-
gy of the study and gave written consent.
2.2. Blood pressure measurements
We performed office blood pressure measurements twice on the
nondominant arm after 10 minutes of rest using Omron M5-I
device (Omron, Kyoto, Japan) and results were averaged. Systolic
blood pressure (SBPoffice), diastolic blood pressure (DBPoffice),
pulse pressure (PPoffice = SBPoffice–DBPoffice) and MAPoffice were
determined. MAPoffice was calculated according to the formula:
MAPoffice=DBPoffice+1/3 PPoffice. Around 24hours ambulatory
blood pressure monitoring (ABPM) was performed with the use
of SpaceLabs 90207 device (SpaceLabs Healthcare, Snoqualmie,
WA) according to ESH expert recommendations.[29] Measure-
ments were performed every 15 minutes during daily activity
(6:00–22:00) and every 20 minutes at night (22:00–6:00). The
above-described approach allowed determining 24hours, day
and night values of systolic blood pressure (SBP24h,SBPD, SBPN),
diastolic blood pressure (DBP24h, DBPD, DBPN), pulse pressure
(PP24h, PPD, PPN) and mean arterial pressure (MAP24h,MAPD,
MAPN).
2.3. Pulse wave analyses
We assessed arterial stiffness parameters by measuring carotid-
femoral PWV and components of central pressure: central
systolic blood pressure (cSBP), and central pulse pressure (cPP) by
applanation tonometry method with the use of SphygmoCor
device integrated with relevant analytical software (AtCor
Medical, Sydney, Australia). The examination was performed
according to expert consensus documents- in supine position,
predominantly at the right common carotid and right common
femoral arteries, after patient’s 10 minutes rest.[20,30] We took 2
measurements and the mean value was included in further
analyses.
2.4. Echocardiographic measurements
We performed all echocardiographic measurements employing 2
independent examiners by using Vivid 7 ultrasound system
(General Electric Healthcare, Milwaukee, WI) equipped with a
harmonic 1.7 to 3.4MHz variable frequency phased-array
transducer. The study protocol was in agreement with ESC
recommendations.[31] LV mass and LVMI were calculated by
using Devereux formula.[32]
LA volume was measured using the modified Simpson’s
method.[31] Maximum LA areas, except for the confluence of
pulmonary veins and the left atrial appendage, were traced in
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apical 2- and 4-chamber views at end systole of the LV. LAVI was
calculated as LA volume/body surface area. To assess intra-
observer and interobserver variabilities in LAVI measurements,
15 patients were randomly selected and measurements were
taken by the main observer at 2 separate occasions and another
independent observer. We computed the coefficient of variation
as the ratio of the mean difference between repeat measurements
to the standard deviation of the paired differences multiplied by
100. Intraobserver and interobserver variabilities were around
4% and 6%, respectively.
The transmitral flow velocity was obtained from the apical
long-axis view with the pulse Doppler method and the early
diastolic mitral peak flow velocity (E), late diastolic mitral peak
flow velocity (A), and their ratio were calculated.
The mitral annular motion velocity was recorded at the LV
lateral and septal wall sites in the apical 4-chamber view by
pulsed tissue Doppler echocardiography. The means of peak
early diastolic motion velocity (e0) at both sites and the ratio of E
to e0 (E/e0) were determined.
Once all clinical examinations were performed, we divided
study group into 2 subgroups based on sex-stratified dichoto-
mized LVMI. The 1 group consisted of patients with LVMI over
the median value and the other group of patients with LVMI
below the median value.
2.5. Statistical analysis
Statistical analyses were performed using STATISTICA 12
software (StatSoft, Inc., Tulsa, OK). The results are expressed
as numerical values and percentages for categorical variables and
mean values± standard deviation for continuous variables.
Comparisons with unrelated groups were made using Student’s
t-test for continuous variables and x2 for qualitative variables.
Analysis of the Pearson correlation coefficient was used to
determine the relation between considered variables and LAVI.
Independent factors’ influence on LAVI were assessed in
univariate and multivariate linear regression models. Differences
were considered statistically significant at P< .05.
3. Results
A total of 205 persons (66% females, 53.6±8.3 years) were
included in this study and divided into 2 subgroups according
to the sex-specific median LVMI value (i.e., 97g/m2 for
women and 110g/m2 for men). Clinical, anthropometric, and
demographic characteristics of study groups are presented in
Table 1.
A higher prevalence of arterial hypertension and diabetes, as
well as higher body mass index (BMI), was observed in
participants with LVMI above median. Those subjects also
had higher PWV, central, peripheral, and ambulatory blood
pressure, and LAVI (Table 1).
The study population consisted of the subjects with a LVEF
within normal range and no signs of regional LV contraction
disturbances.
Table 2 summarizes analyses’ results of relation between LAVI
and other variables including blood pressure values, arterial
stiffness, and echocardiographic parameters in both groups. In
the group with LVMI above median value, LAVI correlated
positively with LVMI and other echocardiographic parameters
including E/e0, but not with blood pressure parameters and
PWV. In the group with LVMI below median value, LAVI
correlated positively with blood pressure parameters, PWV, and
echocardiographic parameters including LVEF, LVMI, and
indices of LV diastolic function.
The relation of LAVI with MAPoffice in study group according
to LVMI median value is presented in Figure 1. Significant
association is observed only among the participants with lower
values of LVMI.
Effect of independent factors (age, gender, PWV, MAPoffice,
andMAP24h) on LAVI in patients with LVMI below and over the
median value was determined by fitting univariate and
multivariate linear regression models.
The results of regression analyses are provided in Table 3.
Among participants with increased LVMI, we observed no
association between LAVI and blood pressure indices. In all
evaluatedmodels only age and gender contributed significantly to
LAVI value in this group. At the same time, in the group with
LVMI below median value, LAVI was influenced by MAPoffice
(b=0.35; P= .004) in Model 4 andMAP24h (b=0.15; P= .045) in
Model 1. Our analyses do not confirm any relation between LAVI
and arterial stiffness index-PWV (Model 1 and Model 2) or the
pulsatile component of blood pressure-cPP (Model 3 and Model
4) in participants with LVMI below, as well as above the median.
4. Discussion
In this cross-sectional study, we found that the LV mass and
function are themain determinants of LAVI. However, in persons
with lower LV mass, LAVI depends on mean arterial pressure,
but not the pulse pressure.
Considering arterial hypertension prevalence in the general
population (reaching an average of 30%)[33] and the prevalence
of left atrium enlargement among hypertensive subjects (over
20%),[34] arterial hypertension is probably the most common
cause of LAE.
Elevated blood pressure induces left atrial enlargement directly
or via LV hypertrophy and, consequently, diastolic dysfunction.
Thus, for better discrimination of these 2mechanisms, we divided
our study group into 2 subgroups below and over the LVMI
median value. The group with LVMI above median value was
characterized by older age, higher BMI, higher prevalence of
arterial hypertension, and diabetes. All of the above-mentioned
variables or clinical conditions promote the development of LV
hypertrophy.[35]
Moreover, the group with higher LVMI had higher blood
pressure parameters (office, ambulatory) and indices of arterial
stiffness-carotid-femoral PWV and central aortic blood pressure,
comparing to the group presenting lower LVMI. Echocardio-
graphic parameters of LV diastolic function were expectedly
worse in the group with LVMI over the median value. Each
cardiovascular variable listed above, including LVMI, may
contribute to LA enlargement.[22,23,36,37] The consequence of
differences listed above is the higher LAVI in the group close to
diagnosis of LV hypertrophy than in the group with LVMI below
median value.
In both groups, LAVI was in significant positive correlation
to LV mass and LVMI. Similar results were obtained for the
association between LA enlargement and the LV hypertrophy
by Katayama and coworkers[38] in a group of adults with
normal LV systolic function. Katayama et al[38] suggested that
elevated LV mass influences more directly left atrium through
the elevation of LV filling pressure than the presence of
hypertension. This conclusion is consistent with our results in
the group with increased LVMI, where neither any blood
pressure parameters, nor arterial stiffness correlated with
Rojek et al. Medicine (2017) 96:52 www.md-journal.com
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LAVI. In contrary, in our group with lower LVMI blood
pressure and arterial stiffness parameters remained in signifi-
cant relation with LAVI. The findings might imply that at
certain stage of LV hypertrophy progression, BP values are of
less importance for further LAE and its pathological con-
sequences like arrhythmia and systemic embolism, than LV
hypertrophy itself. In the interim, BP parameters may influence
LAVI, therefore BP control, independently of antihypertensive
drug used, should prevent LA enlargement. Once LV hypertro-
phy develops along with its hemodynamic consequences for the
LA, more attention should be paid to the antihypertensive
medication choice. Priority should be given to those with
evidence of cardiac hypertrophy prevention in order to
counteract late LAE complications.[27]
Similarly to our results Lantelme et al[21] and Xu et al[39] found
significant relation between arterial stiffness (i.e. carotid-femoral
PWV) and LA diameter, while Janwanishstaporn and Boonya-
sirinant[40] reported the correlation for LAVI, all in the groups of
hypertensive subjects.
Many studies confirmed the link between different blood
pressure parameters and LA diameter or volume.[9,23,26,36] Some
of them indicated that after inclusion of LV mass in the
multivariable regression models, the relations between blood
pressure variables and LA size were no longer statistically
significant.[23]
In other studies, like the Losartan Intervention For Endpoint
Reduction in Hypertension (LIFE) study, systolic blood pressure
was an independent covariate of LA enlargement in patients with
LV hypertrophy, but the odds ratio for this relation was only 1.01
(95%CI: 1.002–1.02). For comparison, the odds ratio in the
relation between LV hypertrophy and LA enlargement in LIFE
study was 2.46 (95%CI: 1.76–3.45).[9]
Table 1
Clinical characteristics of study participants according to sex-specific median of left ventricle mass index (LVMI).
Clinical
characteristics
All
participants
LVMI
below median value
LVMI
over median value P value
No. 205 102 103
Age, years 53.6±8.3 51.2±8.6 56.0±7.3 <.001
Female, % 136 (66) 68 (66) 68 (66) .96
Body mass index, kg/m2 27.5±4.5 26.4±4.3 28.6±4.4 .004
Hypertension, % 102 (50) 41 (40) 63 (61) <.001
Diabetes, % 16 (8) 4 (4) 13 (13) .04
Smoker, % 22 (11) 9 (9) 14 (14) .29
Antihypertensive medication, % 82 (40) 35 (34) 53 (51) .02
Office BP, mm Hg
SBPoffice 142.3±18.2 136.3±15.2 148.2±19.1 <.001
DBPoffice 84.0±10.9 82.1±9.6 85.9±11.7 .03
PPoffice 58.2±13.2 54.1±10.9 62.3±14.0 <.001
MAPoffice 103.4±12.3 100.2±10.6 106.6±13.1 .002
BP from ABPM, mm Hg
SBP24h 122.3±12.7 119.2±11.2 125.4±13.4 .007
DBP24h 74.3±7.8 73.1±7.1 75.5±8.4 .06
PP24h 48.0±8.6 46.1±7.9 49.9±9.0 .03
MAP24h 90.3±8.9 88.5±7.9 92.2±9.4 .02
SBPD 128.1±13.5 125.0±12.2 131.1±14.1 .02
DBPD 79.1±8.8 77.9±7.6 80.2±9.6 .17
PPD 49.0±9.8 47.1±8.8 50.9±10.5 .05
MAPD 95.4±9.5 93.6±8.5 97.2±10.2 .05
SBPN 110.9±13.2 107.3±10.7 114.5±14.4 <.001
DBPN 65.1±8.5 63.6±7.6 66.7±9.0 .02
PPN 45.8±8.7 43.7±7.8 47.8±9.1 .009
MAPN 80.4±9.4 78.1±8.0 82.6±10.2 .003
Central BP, mm Hg
cSBP 129.0±17.6 123.8±15.9 134.2±17.9 <.001
cPP 45.3±12.6 41.8±11.6 48.7±12.5 <.001
PWV (m/s) 10.0±2.1 9.4±1.9 10.6±2.1 .001
Echocardiographic parameters
LAV, mL 48.6±16.2 41.7±13.8 55.5±15.5 <.001
LAVI, mL/m2 25.4±7.5 22.2±6.3 28.5±7.2 <.001
LVEF, % 68.5±8.1 69.7±6.7 67.3±9.1 .03
LVMI, g/m2 103.1±23.4 84.7±12.7 121.3±16.2 <.001
E, cm/s 69.6±17.9 72.3±18.2 66.9±17.2 .10
A, cm/s 69.2±16.6 65.0±16.7 73.5±15.4 <.001
E/A () 1.1±0.4 1.2±0.4 0.9±0.3 <.001
e0, cm/s 8.8±3.2 9.7±3.6 7.8±2.4 <.001
E/e0 () 8.5±2.6 8.1±2.6 8.9±2.6 .013
Data are shown as mean±SD or number (%).
24h=24 hours, A= late diastolic mitral peak flow velocity, c= central, D=day, DBP=diastolic blood pressure, e0=early diastolic velocities of septal and lateral mitral annulus (mean) obtained in tissue Doppler
imaging, E= early diastolic mitral peak flow velocity, HR=heart rate, LAV= left atrial volume, LAVI= left atrial volume index, LVEF= left ventricle ejection fraction, LVMI= left ventricle mass index, MAP=mean
arterial pressure, N=Night, PP=pulse pressure, PWV=pulse wave velocity, SBP= systolic blood pressure.
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According to our results from a selected sample of the general
population, we suggested that in subjects who are older, with a
higher prevalence of arterial hypertension, and with increased
LVMI, LV mass is crucial for LA enlargement. In younger
subjects with a lower blood pressure, lower prevalence of
hypertension and other comorbidities, like diabetes and
consequently, lower LVMI, blood pressure and arterial stiffness
parameters are more significant for LA enlargement. The last
finding is of special importance when we consider LA
enlargement as an early sign of hypertensive heart disease.
Su et al., in a group of patients with early stages of arterial
hypertension, found a 57% incidence of LA enlargement.[37]
In the group of patients where LVMI is not the predominant
variable determining left atrium volume, it is a point of interest,
which component of blood pressure is closer related with left
atrium volume index.
Vaziri et al[23] proved a significant correlation between LA size
and BP parameters including SBP, PP, and MAP. However, after
adjustment for BMI and age, only SBP and PP did have a
significant contribution to LA size.
Among hypertensive patients in the study of Cuspidi and
coworkers in multivariate correlation analysis systolic and pulse
pressure correlated positively and diastolic blood pressure
negatively with left atrium size. MAP value was not included
in this analysis.[26]
Similar results indicating PP as a determinant of LA
enlargement were demonstrated by other investigators.[24,25] In
diabetic subjects, Zapolski and Wysokinski[36] demonstrated a
correlation between PP and LAVI and lack of correlation between
LAVI and aortic DBP, which is mainly reflected the steady
component of blood pressure.
Contrary to the results cited above, in our group of patients
with LVMI below median value, LAVI was in significant
association with MAP values, but not with PP values. Regression
models we fitted supported the clear distintion of relevant BP
components influence on LAVI. We namely assumed introduc-
tion only 1 BP variable measured in given settings and
representing steady or pulsatile BP component to eliminate
multicollinearity (e.g., MAPoffice measured using Omron device
and cPP measured by SphygmoCor). Different approach to
regression models’ construction (including more than 1 BP
variable in category) was proposed by Mulè and coworkers[41]
Table 2
Relation of anthropometric, hemodynamic and echocardiographic
measurements with left atrial volume index (LAVI) according to
sex-specific median of left ventricle mass index (LVMI) value.
LVMI
below median value
LVMI
over median value
Correlation coefficient in all cases (r)
Age (y) 0.31
∗
0.15
Office BP, mm Hg
SBPoffice 0.37
# 0.11
DBPoffice 0.28
∗
0.07
PPoffice 0.28
∗
0.09
MAPoffice 0.35
∗
0.09
BP from ABPM, mm Hg
SBP24h 0.23
∗ 0.02
DBP24h 0.67 0.01
PP24h 0.27
∗
0.06
MAP24h 0.15 0.06
SBPD 0.20
∗ 0.01
DBPD 0.08 0.09
PPD 0.21
∗
0.06
MAPD 0.15 0.06
SBPN 0.23
∗ 0.04
DBPN 0.13 0.00
PPN 0.19 0.06
MAPN .019 0.02
Central BP, mm Hg
cSBP 0.35# 0.11
cPP 0.26
∗
0.12
PWV, m/s 0.28
∗
0.00
LVEF, % 0.22∗ 0.21∗
LVMI, g/m2 0.28
∗
0.36#
E, cm/s 0.04 0.17
A, cm/s 0.26
∗
0.09
E/A () 0.24∗ 0.07
e0, cm/s 0.21∗ 0.15
E/e0 () 0.23∗ 0.24∗
24h=24 hours, A= late diastolic mitral peak flow velocity, c=central, D=day, DBP=diastolic blood
pressure, e0=early diastolic velocities of septal and lateral mitral annulus (mean) obtained in tissue
Doppler imaging, E= early diastolic mitral peak flow velocity, HR=heart rate, LAV= left atrial volume,
LAVI= left atrial volume index, LVEF= left ventricle ejection fraction, LVMI= left ventricle mass index,
MAP=mean arterial pressure, N=night, PP=pulse pressure, PWV= carotid-femoral pulse wave
velocity, r= correlation coefficient in all cases, SBP= systolic blood pressure;
∗
P< .05.
# P< .001.
5.
15.
25.
35.
45.
55.
70. 80. 90. 100. 110. 120. 130. 140.
LA
V
I, 
m
L/
m
2
MAPoffice, mm Hg
LVMI below median; dotted trend line
LVMI over median; solid trend line
Figure 1. Open rhomb and dotted line represent the relation of left atrium
volume index (LAVI) to office mean blood pressure (MAP office) in participants
with left ventricle mass index (LVMI) below median value. Model equation:
LAVI=1.73+0.21
∗
MAPoffice; P< .001. Full square and solid line represent
relation of left atrium volume index (LAVI) to office mean blood pressure (MAP
office) in participants with left ventricle mass index (LVMI) over median value.
Model equation: LAVI=20+0.07
∗
MAPoffice; P= .22. LAVI- left atrial volume
index; LVMI- left ventricle mass index; MAPoffice- office mean arterial pressure.
LAV= left atrial volume index; LVMI= left ventricle mass index; MAPoffice=office
mean arterial pressure.
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who presented interesting observation of BP components
predicting LV hypertrophy.
MAP measurement methodology may substantially influence
the study results, thus, we employed more than 1 BP evaluation
method. MAP24h is considered to be more informative as it is
derived from multiple, circadian, core measurements, unlike
MAPoffice. Importantly, MAP parameters measured in different
settings were proved to be significant predictors of LAVI,
however MAPoffice was considerably stronger. The models
including MAPoffice explained 16% to 23% of LAVI variability,
comparing to 10% for MAP24h.
MAP, considered as a steady component of BP from the
physiological point of view, is the function of cardiac output,
systemic vascular resistance, and central venous pressure. In
subjects with normal LV systolic function and cardiac output, as
in the case of our study, the main factor determining MAP is
systemic vascular resistance. As evident from the formula for
MAP, MAP=DBP+1/3 (SBP-DBP). Both, SBP and DBP, are in
strong positive associationwith cardiac afterload, one of the most
important factors responsible for LV hypertrophy development.
Thus, it is not surprising thatMAPwas associated positively with
LV wall thickness and negatively with LV diastolic function in a
large cohort in the Framingham Heart Study. In Framingham
study PP was associated, similarly toMAP, with LV diameter and
wall thickness, but additionally with LV systolic function.[42]
Darne and coworkers reported stronger relation of LV
hypertrophy with steady than pulsatile BP component.[43] In
essential hypertensives, older than 50 years, Mulè and
coworkers[41] found significant independent association between
LV hypertrophy and both PP24h and MAP24h, however in
younger than 50 years only MAP was associated with LVH.
Because LAE is usually the consequence of LV hypertrophy
and impaired LV filing we may expect similar stronger relation
between MAP and LAVI than PP and LAVI.
Of note, in the Physicians’Health Study MAP next to SBP and
DBP strongly predicted cardiovascular diseases (CVD) in
younger man, whereas either average SBP or PP predicted
CVD among older.[44] Calculation of LAVI in early stages of
arterial hypertension, as well as in patients with low estimated
cardiovascular risk, with no signs of LV hypertrophy or arterial
stiffness (low PWV and PP values), may provide new information
about their cardiovascular risk.
Our results should be considered within the context of the
limitations of our study. The study group consisted of
participants from a specified age range (40–65 years) which
was optimal to evaluate the early signs of heart remodeling. For
this reason, the results of the study should be extrapolated for the
general population with caution. We used median value of LVMI
to distinguish groups with or without a tendency for LV
hypertrophy, which is more appropriate for the general
population than using defined cut-off points recommended by
guidelines for hypertensive patients.[27] Of note, 50% of study
group was diagnosed for arterial hypertension. Expectedly,
hypertension was more prevalent in the group with higher LVMI,
however the frequency and type of antihypertensive medication
used was comparable; thus we did not expect any differences in
the results obtained secondary to the medication used, which was
confirmed in sensitivity analysis.
5. Conclusions
LV mass and function are the main determinants of LAVI.
However, in persons with lower LV mass, LAVI depends on the
steady component of blood pressure, but not the pulsatile one.
Increased LAVI reflects early changes in response to systemic
blood pressure elevation.
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